| Renodyra 1080mg modified release tablets | Renodyra is an alkalizing agent and indicated in adults for:
• The treatment of patients with kidney stones and hypocitraturia, or chronic calcium oxalate stones.
• The treatment and prevention of recurrent uric acid lithiasis with or without calcium lithiasis and cystine lithiasis.
• The treatment of renal tubular acidosis with calcium nephrolithiasis. | 3 tablets per day = £1.86 (Mild) |
